Get started
Author

Nelma Cristina D. Clementino

Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase
2018 · François-Xavier Mahon, Carla Boquimpani, et al. · Annals of Internal Medicine · 134
Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib
2014 · Timothy P. Hughes, Jeffrey H. Lipton, et al. · Blood · 98
Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update
2021 · Timothy P. Hughes, Nelma Cristina D. Clementino, et al. · Leukemia · 47
research paper: IL1RN VNTR and IL2−330 polymorphic genes are independently associated with chronic immune thrombocytopenia
2010 · Andreia Maria Camargos Rocha, Cláudia De Souza, et al. · British Journal of Haematology · 32
PDF
De novo acute myeloid leukemia in adults younger than 60 years of age: Socioeconomic aspects and treatment results in a Brazilian university center
2006 · Evandro M. Fagundes, Vanderson Rocha, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 32
Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop
2016 · Timothy P. Hughes, Carla Maria Boquimpani, et al. · Blood · 21
Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with second-line nilotinib (NIL): First results from the ENESTop study.
2016 · Timothy P Hughes, Carla Boquimpani, et al. · Journal of Clinical Oncology · 13
The serum levels of the cytokines involved in the Th17 and Th1 cell commitment are increased in individuals with borderline thrombocytopenia
2013 · Andreia Maria Camargos Rocha, Cláudia Souza, et al. · Journal of Hematology & Oncology · 12
PDF
Patient-Reported Quality of Life before and after Stopping Treatment in the ENESTop Trial of Treatment-Free Remission for Patients with Chronic Myeloid Leukemia in Chronic Phase
2016 · François-Xavier Mahon, Carla Maria Boquimpani, et al. · Blood · 11
ENESTop 192-week results: Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) after stopping second-line (2L) nilotinib (NIL).
2019 · Timothy P. Hughes, Carla Boquimpani, et al. · Journal of Clinical Oncology · 9
Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia - a Multicenter, Observational Study
2018 · Katia B Pagnano, Carmen Fava, et al. · Blood · 8
Guideline on myeloproliferative neoplasms: Associacão Brasileira de Hematologia, Hemoterapia e Terapia Cellular
2019 · Renato Sampaio Tavares, Alexandre Nonino, et al. · Hematology Transfusion and Cell Therapy · 7
PDF
Long-term treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) after stopping second-line (2L) nilotinib: ENESTop 144-wk results.
2018 · François-Xavier Mahon, Carla Boquimpani, et al. · Journal of Clinical Oncology · 7
Granulocytic sarcoma of the stomach
2010 · Antonio Vaz Macedo, Izabela F. Freitas, et al. · Hematology/Oncology and Stem Cell Therapy · 6
PDF
ENESTop 192-Weeks Results: Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib
2019 · Francois-Xavier Mahon, Carla Boquimpani, et al. · Clinical Lymphoma Myeloma & Leukemia · 4
Lack of Association Between N-ras Gene Mutations and Clinical Prognosis in Brazilian Children with Acute Lymphoblastic Leukemia
2001 · Nelma Cristina Diogo Clementino, Mihoko Yamamoto, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 4
ENESTop 5-Year Update: Durability of Treatment-Free Remission Following Second-Line Nilotinib and Exploratory Analysis of Molecular Response Regain after Nilotinib Re-Initiation in Patients with Chronic Myeloid Leukemia
2020 · Francois-Xavier Mahon, Nelma D Clementino, et al. · Blood · 3
Covid-19 in Chronic Myeloid Leukemia Patients – Brazilian Experience
2020 · K.B.B. Pagnano, A.C. Toreli, et al. · Hematology Transfusion and Cell Therapy · 3
Financial Impact of Imatinib Discontinuation in Brazil - a Pharmoeconomic Study
2019 · Renato Torrescasana Centrone, Isabel Bonafe, et al. · Blood · 3
ENESTop 144-Week Update: Long-Term Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib
2018 · Timothy P. Hughes, Carla Boquimpani, et al. · Clinical Lymphoma Myeloma & Leukemia · 3
Effect of continued imatinib (IM) in pts with detectable BCR-ABL after ≥ 2 years on study on deep molecular responses (MR): 36-month update from ENESTcmr.
2014 · Nelson Spector, Nelma Cristina D. Clementino, et al. · Journal of Clinical Oncology · 1
COVID-19 in Chronic Myeloid Leukemia Patients - Brazilian Experience
2020 · Katia B Pagnano, Ana Carolina Mourão Toreli, et al. · Blood
]Socioeconomic Factors May Select Adults Younger Than 60 Years of Age with “De Novo” Acute Myeloid Leukemia To Receive Intensive Treatment outside a Clinical Trial in Developing Countries. Experience of a Brazilian University Center.
2004 · Evandro M. Fagundes, Vanderson Rocha, et al. · Blood
Works count: 24
Citation count: 458
H-index: 9
I10-index: 9
Year
Topic
Type